INCREASED ANGIOTENSIN CONVERTING ENZYME IN MURINE SCHISTOSOMIASIS - EFFECTS OF CAPTOPRIL AND MK-421

被引:0
|
作者
SILVERSTEIN, E
EVELAND, LK
FRIEDLAND, J
STANEK, AE
DIAMOND, HS
BUSH, ME
COHEN, L
机构
[1] SUNY DOWNSTATE MED CTR,DEPT MED,BROOKLYN,NY 11203
[2] SUNY DOWNSTATE MED CTR,DEPT PATHOL,BROOKLYN,NY 11203
[3] SUNY DOWNSTATE MED CTR,DEPT MICROBIOL & IMMUNOL,BROOKLYN,NY 11203
来源
CLINICAL RESEARCH | 1982年 / 30卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A404 / A404
页数:1
相关论文
共 50 条
  • [41] STUDIES ON ELEVATED ANGIOTENSIN-CONVERTING ENZYME IN MURINE SCHISTOSOMIASIS
    SILVERSTEIN, E
    EVELAND, LK
    FRIEDLAND, J
    COHEN, L
    CLINICAL RESPIRATORY PHYSIOLOGY-BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE, 1981, 17 (05): : P62 - P62
  • [42] CORRELATION BETWEEN INHIBITION OF RENIN-ANGIOTENSIN SYSTEM AND ANTIHYPERTENSIVE EFFECT OF MK-421 AND CAPTOPRIL IN 2-KIDNEY, 1-CLIP RENAL HYPERTENSIVE RATS AFTER A SINGLE AND REPEATED ORAL-ADMINISTRATION OF MK-421 OR CAPTOPRIL
    OHMURA, I
    MAKI, E
    NARUSE, T
    IKEDA, N
    ASAMI, T
    SAGAWA, N
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 86 (04) : 303 - 313
  • [43] EFFECTS OF ENALAPRIL MALEATE (MK-421) ON RENOVASCULAR HYPERTENSION
    OGAWA, K
    MATSUNAGA, M
    NAGAI, H
    HARA, A
    KOIDE, H
    PAK, CH
    HIRAKAWA, A
    KAWAI, C
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 145 (02): : 125 - 135
  • [44] REVERSAL OF DIURETIC-INDUCED SECONDARY HYPER-ALDOSTERONISM AND HYPOKALEMIA BY ENALAPRIL (MK-421) - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    GRIFFING, GT
    SINDLER, BH
    AURECCHIA, SA
    MELBY, JC
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (07): : 711 - 716
  • [45] ANTIHYPERTENSIVE EFFICACY OF MK-421 (AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CEI) AND HYDROCHLOROTHIAZIDE (HTZ) IN CONSCIOUS DAHL SENSITIVE (S) AND RESISTIVE (R) RATS
    SHARMA, JN
    FERNANDEZ, PG
    KIM, BK
    TRIGGLE, CR
    CLINICAL RESEARCH, 1983, 31 (02): : A335 - A335
  • [46] REFLEX-HEMODYNAMIC ADJUSTMENTS AND BAROREFLEX SENSITIVITY DURING CONVERTING ENZYME-INHIBITION WITH MK-421 IN NORMAL HUMANS
    IBSEN, H
    EGAN, B
    OSTERZIEL, K
    VANDER, A
    JULIUS, S
    HYPERTENSION, 1983, 5 (02) : I184 - I191
  • [47] EFFICACY OF MK-421, A NONSULFHYDRYL-CONTAINING CONVERTING-ENZYME INHIBITOR, IN LOW RENIN ESSENTIAL-HYPERTENSION
    WILKINS, LH
    OPARIL, S
    DUSTAN, HP
    ODYA, C
    CLINICAL RESEARCH, 1982, 30 (05): : A869 - A869
  • [48] EFFECT OF THE CONVERTING ENZYME-INHIBITOR (CEI) MK-421 ON ISCHEMIC ACUTE-RENAL-FAILURE (ARF) IN THE RAT
    KOELZ, AM
    BRUNNER, FP
    WUNDERLICH, P
    THIEL, GT
    KIDNEY INTERNATIONAL, 1983, 23 (06) : 902 - 902
  • [49] HUMORAL AND RENAL EFFECTS OF MK-421 (ENALAPRIL) IN HYPERTENSIVE SUBJECTS
    DELEEUW, PW
    HOOGMA, RPLM
    VANSOEST, GAW
    TCHANG, PT
    BIRKENHAGER, WH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) : 731 - 736
  • [50] MK-421 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - NEUROHUMORAL CORRELATES OF THE HEMODYNAMIC-RESPONSE TO ACUTE AND CHRONIC THERAPY
    DICARLO, L
    CHATTERJEE, K
    ATHERTON, B
    CURRAN, D
    PARMLEY, W
    CLINICAL RESEARCH, 1983, 31 (02): : A179 - A179